Search Results
Results found for "GREGORY TALL"
- Increased Anxiety-like Behaviors in Adgra1-/- Male But Not Female Mice are Attributable to...
the open field, elevated plus maze, and light-dark box tests, with normal depression levels in the tail-suspension
- Use of CRISPR/Cas9-edited HEK293 cells reveals that both conventional and novel protein kinase C...
activation of PKC and mutation of rat mGlu5a Ser901, a PKC-dependent phosphorylation site in the receptor C-tail
- PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design
Point mutations are in the C-tail of PAR4 PH-binding domain; F347 L and D349A, but not E346A, abrogate
- Inside the New Dr. GPCR Ecosystem: Learning, Insight, and Momentum for 2026
Latest breakthroughs : Lilly confirms Q4 2025 results call; Novo Nordisk explores monthly GLP-1 acquisition from conferences to collaborative initiatives built in public. 👉 Email us to chat, collaborate and tell
- Asking Better Questions in Science: A Practical Guide for Emerging Researchers
Yet one well-timed question can unlock clarity, accelerate a stalled project, or even spark a collaboration
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
Concentrations rise and fall. Clearance happens. And drugs only work when they’re bound.
- Allosteric ligands control the activation of a class C GPCR heterodimer by acting at the transmembra
They often form homo- and heterodimers with allosteric cross-talk between receptor entities, which contributes
- Novel interaction between neurotrophic factor-α1/carboxypeptidase E and serotonin receptor, 5-HTR1E,
Furthermore, after phosphorylating the C-terminal tail and intracellular loop 3 (ICL3) of NF-α1/CPE-5
- Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology
Misreading Antagonism Delays GPCR Drug Discovery If a dose-response curve shifts to the right, you might call
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
As Kenakin explains, all GPCR signaling is allosteric , and pretending otherwise introduces risk at every These changes can alter how the receptor talks to G proteins, arrestins, or other receptors. Affinity tells part of the story.
- 📢 GPCR Update: August 19-25, 2024 | Thrilling Announcement: New Pharmacology Course Dates & Exclusive Discounts Inside!
Innovation Forum Nxera Pharma Notes Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568 Call
- 📰 GPCR Weekly News
Advisory Board with appointment of immuno-oncology experts More millions roll in for Sosei Heptares Call
- Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs
They stall when chemistry, modeling, and pharmacology drift apart. All masterclasses — past and upcoming — are included with Premium Membership.
- Early Safety Assays: Identifying Showstoppers in GPCR Drug Discovery Pipelines Early
mechanisms demand immediate attention, and how to build robust decision points into the cascade without falling Kenakin, monthly live AMAs, and a growing library of on-demand content—all focused on sharpening discovery
- Scientific Isolation: The Real Reason Early Biotechs Lose Traction
. 👉 What it looks like in real life: Meetings end with explanations, not decisions BD calls “went great
- From Farm Fields to GPCR Discovery, GLP-1 and GIP
Surgery electives meant long nights, constant patient responsibilities, and unpredictable call schedules
- 📰 GPCR Weekly News, October 2 to 8, 2023
million to development of databases supporting medical research ‘Define your own success’: Duke leaders talk
- Irreversible Drugs, Real Control: Design for Durable Target Engagement
. ➤ 🎓 Full GPCR University + 🔬 200+ expert talks 🗞️ Weekly research, careers & event intelligence
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
. 🚀 Join Premium Today & Enjoy ➤ 🎓 Full GPCR University + 🔬 200+ expert talks 🗞️ Weekly research,
- GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors
Here’s who we've talked to so far: 🎥 Check out the interview with Dr.
- Fluorescence Polarization in GPCR Research
Using this method, binding affinity, kinetics and selectivity can all be measured and used to establish equipment for analysis and plate readers are usually available in regular laboratories, although not all Table 1.
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
Part 5: Your Precision Blueprint : I'll tie it all together, providing a concise, actionable guide for scientific and operational guidance to accelerate discovery . 🚀 Book your free 30-minute strategy call
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
Sharpen your discovery decisions ➤ GPCR Signal Transduction Call for Papers: Define What Comes Next Volume signals today will shape tomorrow’s breakthroughs—and avoid delays others won’t see coming. 👉 Access all
- Chemical signaling regulates axon regeneration via the GPCR-Gqα pathway in Caenorhabditis elegans
C. elegans secretes a family of small-molecule pheromones called ascarosides, which serve various functions
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
Pipeline Efficiency Begins With the Chemistry Itself Drug discovery pipelines often stall not because
- 📰 GPCR Weekly News, April 17 to 23, 2023
Submit your interest in giving a talk or presenting a poster to Hello@DrGPCR.com. Don't miss out!
- 📰 GPCR Weekly News - January 2 to 8, 2023
Sherwin Sells 30,000 Shares STALICLA signs agreement with Novartis on neurodevelopmental disorders Call
- 📰 GPCR Weekly News, October 23 to 29, 2023
We're proud sponsors and can't wait to connect with all of you. See you there! Find speaker details on the Live Talks page and mark your calendar HERE.
- 📰 GPCR Weekly News
Special report 2022: Meet 20 women blazing trails in biopharma R&D ERNEST - 2022 Scientific Outputs Call
- Your GPCR Program Decisions Depend on Good Data Interpretation
publications : AlphaFold3 benchmarking for GPCRs; new structural insights into peptide ligand activation All Don’t Fall Behind—Access the Edge You Need 👉 Access all the news and upcoming events ➤ Already a Premium



















